Overall, the rapid establishment of CRC-PDE cultures and their long duration are advantages for their application to guide patient treatment selection and potentially avoid overtreatment of non-responsive disease in the adjuvant setting. The gene discussed is ALDH7A1; the disease is colorectal carcinoma.